ROYAL BANK OF CANADA: ROM position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ROYAL BANK OF CANADA on ROM, newest first. How the timeline and the estimate are built.
ROYAL BANK OF CANADA held 64 ROM shares at 2026-06-30 per its 13F-HR filed 2026-08-14.
the latest 13F is the newest step
- period ended2026-06-3013F 64 sharesChange vs previous 13F 0 shares
<0.01% of the 13F portfolio, value $10,000.
13F-HR 0001140361-26-033080 filed by ROYAL BANK OF CANADA
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 64 sharesChange vs previous 13F -647 shares
<0.01% of the 13F portfolio, value $5,000.
13F-HR 0001140361-26-021585 filed by ROYAL BANK OF CANADA
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 711 sharesChange vs previous 13F +405 shares
<0.01% of the 13F portfolio, value $67,000.
13F-HR 0001140361-26-005577 filed by ROYAL BANK OF CANADA
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 306 sharesChange vs previous 13F -324 shares
<0.01% of the 13F portfolio, value $28,000.
13F-HR 0001140361-25-042265 filed by ROYAL BANK OF CANADA
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F/A 630 sharesChange vs previous 13F +566 shares
<0.01% of the 13F portfolio, value $48,000.
13F-HR/A 0001140361-25-042957 filed by ROYAL BANK OF CANADA
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F/A 64 sharesChange vs previous 13F not available
<0.01% of the 13F portfolio, value $3,000.
13F-HR/A 0001140361-25-042953 filed by ROYAL BANK OF CANADA
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).